Dr. Gurram is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Center Dr
Bldg 10
Bethesda, MD 20892Phone+1 240-858-3700
Education & Training
National Institutes of Health Clinical CenterFellowship, Minimally Invasive Urologic Surgery, 2018 - 2021
Zucker School of Medicine at Hofstra/NorthwellResidency, Urology, 2014 - 2018
Indiana University School of MedicineClass of 2013
Certifications & Licensure
MD State Medical License 2023 - 2026
DC State Medical License 2018 - 2024
Clinical Trials
- Study to Determine Possible Effects of Apalutamide on EGFR Expression in Patients With Non-muscle Invasive Bladder Cancer Start of enrollment: 2024 Jun 15
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 14 citationsClinical value of 18FDG PET/MRI in muscle-invasive, locally advanced, and metastatic bladder cancer.Ali Cahid Civelek, Scot Anthony Niglio, Ashkan A. Malayeri, Jeffrey Lin, Sandeep Gurram
Urologic Oncology. 2021-06-16 - 36 citationsWhy Does Magnetic Resonance Imaging-Targeted Biopsy Miss Clinically Significant Cancer?Cheyenne Williams, Michael Ahdoot, Michael Daneshvar, Christian Hague, Andrew R Wilbur
The Journal of Urology. 2021-08-26 - 459 citationsMRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer DiagnosisMichael Ahdoot, Andrew R Wilbur, Sarah E Reese, Amir H. Lebastchi, Sherif Mehralivand
The New England Journal of Medicine. 2020-03-04
Press Mentions
For Common Form of Bladder Cancer, Chemo Combo Effective Alternative to BCGAugust 29th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
